On Tuesday, February 3, the next meeting of the Transparency Council.
AOTMiT: Transparency Council on psoriasis, hematooncology and forensic psychiatry, among others
Published Feb. 2, 2026 06:56
The agenda includes:
1. preparation of positions on the evaluation of the drug Spevigo (spesolimabum) within the framework of the drug program B.47. "Treatment of patients with psoriasis (ICD-10 L40.0 L40.1)": 1) concentrate for solution for infusion, 2) solution for injection in an ampoule-syringe.
2 Prepare a position paper on the evaluation of the drug Brukins (zanubrutinibum) within the framework of the drug program B.79. "Treatment of patients with chronic lymphocytic leukemia or small B-cell lymphoma (ICD-10: C91.1)".
3 Prepare a position paper on the qualification of the health care service "Comprehensive outpatient and day health care services including diagnosis and treatment provided under the security measure of forensic psychiatry".
4 Prepare a position paper to examine the appropriateness of issuing reimbursement approvals for the medicinal product Iwilfin (eflornithine) for the indication: maintenance treatment of recurrent neuroblastoma in remission.
5 Prepare an opinion on the draft health policy program of the local government unit "Health policy program in the field of diagnosis of developmental defects and disorders in socially disadvantaged children from birth to 18 years of age in Lower Silesia".
Source: AOTMiT
